Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
| Status: | Completed |
|---|---|
| Conditions: | Allergy, Ocular |
| Therapuetic Areas: | Ophthalmology, Otolaryngology |
| Healthy: | No |
| Age Range: | 10 - Any |
| Updated: | 11/19/2016 |
| Start Date: | August 2006 |
A Comparative Study of Olopatadine 0.2% Versus Vehicle in Patients With Seasonal Allergic Conjunctivitis or Rhinoconjunctivitis
The purpose of this study is to demonstrate that Olopatadine 0.2% is superior to vehicle in
the treatment of the signs and symptoms associated with allergic conjunctivitis or
rhinoconjunctivitis.
the treatment of the signs and symptoms associated with allergic conjunctivitis or
rhinoconjunctivitis.
Inclusion Criteria:
- History of seasonal allergic conjunctivitis or rhinoconjunctivitis, a positive grass
antigen challenge reaction (skin test), and a positive response to grass in the
Conjunctival Allergen Challenge (CAC) model
Exclusion Criteria:
- Under 10 years of age
We found this trial at
1
site
Click here to add this to my saved trials
